Results 151 to 160 of about 134,090 (261)

Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2‐Year Post‐Marketing Surveillance Data

open access: yesNeurology and Clinical Neuroscience, Volume 14, Issue 1, Page 54-68, January 2026.
ABSTRACT Background Dimethyl fumarate (DMF) is an orally administered disease‐modifying drug used for the treatment of multiple sclerosis (MS) in numerous countries worldwide. Aim An ongoing post‐marketing surveillance (PMS) is assessing the real‐world safety and effectiveness of DMF in Japanese patients with MS.
Hirofumi Ochi   +15 more
wiley   +1 more source

Diagnostic Significance of Combining Telomerase Activity with CYFRA21-1 Level in Differentiating Malignant Pleural Effusion Caused by Lung Cancer from Benign Pleural Effusio

open access: yesChinese Journal of Lung Cancer, 2010
Background and objective Telomerase and CYFRA21-1 may be positively expressed in malignant pleural effusion, but the sensitivity and specificity of single tumor marker were low.
Hongmei LI   +3 more
doaj  

Management of Pediatric and Adolescent Rhabdomyosarcoma of the Chest Wall: An Expert Consensus Opinion From the International Soft Tissue Sarcoma Consortium (INSTRuCT)

open access: yesPediatric Blood &Cancer, Volume 73, Issue 1, January 2026.
ABSTRACT The International Soft‐Tissue Sarcoma Consortium (INSTRuCT) was established as a global partnership among various pediatric soft tissue sarcoma groups, including the Children's Oncology Group (COG), European Pediatric Soft Tissue Sarcoma Group (EpSSG), and Cooperative Weichteilsarkom Studiengruppe (CWS). One of INSTRuCT's primary objectives is
Andreas Schmidt   +8 more
wiley   +1 more source

From Clusters to Outcomes: Machine Learning‐Based Phenotyping in Intermediate–High‐Risk Acute Pulmonary Embolism

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Intermediate–high‐risk (IHR) pulmonary embolism (PE) represents a heterogeneous group in whom guideline‐based criteria may insufficiently capture biologic and hemodynamic variability relevant to early deterioration. Data‐driven phenotyping may improve risk stratification and support individualized decisions regarding reperfusion therapy.
Barkin Kultursay   +19 more
wiley   +1 more source

Isolated Mediastinal and Hilar Lymphadenopathy as a Manifestation of IgG4‐Related Disease Diagnosed by EBUS‐Guided Transbronchial Mediastinal Cryobiopsy

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
We describe a case of mediastinal and hilar lymphadenopathy diagnosed as IgG4‐RD by transbronchial mediastinal cryobiopsy, fulfilling the 2020 diagnostic criteria, with systemic evaluation confirming no other organ involvement. ABSTRACT Immunoglobulin G4‐related disease (IgG4‐RD) is a fibroinflammatory condition that can involve multiple organs ...
Wen Zhang   +7 more
wiley   +1 more source

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions [PDF]

open access: gold, 2019
Abdelsadek H. Al-Aarag   +7 more
openalex   +1 more source

Hemothorax as the Initial Manifestation of KRAS G12D Positive Pulmonary Pleomorphic Carcinoma: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
We report a rare case of KRAS G12D positive pulmonary pleomorphic carcinoma penetrating the visceral pleura, leading to rapid tumour growth and uncontrolled hemothorax. In addition to the high proliferative and invasive potential of the tumour, the oncological properties of the KRAS G12D mutation likely precipitated both the abrupt onset and recurrence
Takuma Ikeda   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy